article thumbnail

University Hospitals now offering FDA-approved medication for treatment of Alzheimer’s disease

SCIENMAG: Medicine & Health

CLEVELAND—University Hospitals (UH) Brain Health & Memory Center is now treating patients with LEQEMBI® (lecanemab), a Food and Drug Administration-approved medication for the treatment of Alzheimer’s disease.

article thumbnail

Immuno-oncology innovations redefining cancer treatment in 2024

Drug Target Review

What innovative approaches and technologies are anticipated to reshape immuno-oncology treatments in 2024? Immuno-oncology, notably through checkpoint inhibitors, has significantly reshaped cancer treatment over the past decade. Espen integrates clinical and research expertise as Director of Medical Affairs.

Treatment 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is It Really Pneumonia? Study Casts Doubt on Hospital Diagnoses

Drugs.com

6, 2024 -- Hospitals could be frequently misdiagnosing pneumonia, causing patients to receive the wrong treatments and potentially become deathly ill, a new study finds.More than half the time, a pneumonia diagnosis will change. TUESDAY, Aug.

article thumbnail

Cancer Patients Get Poorer Care at Hospitals Serving Minority Communities

Drugs.com

THURSDAY, May 30, 2024 -- Cancer patients receive less effective treatment at hospitals that mainly serve minority communities, a new study shows.More than 9% of cancer patients are treated at hospitals where a significant percentage of patients.

article thumbnail

Merck antibody reduces RSV-related disease, hospitalizations in trial

BioPharma Drive: Drug Pricing

Detailed data from a Phase 2b/3 study of Merck’s treatment clesrovimab should support the company’s efforts to win approval by the 2025-2026 season.

Hospitals 111
article thumbnail

Post-Trauma Support Can Prevent Repeat Hospitalizations

Drugs.com

27, 2023 -- When hospitals support trauma survivors' mental health during and after treatment, patients are less likely to return in crisis, researchers report.There's no uniform guidance on how to offer mental health services to. WEDNESDAY, Dec.

article thumbnail

Buprenorphine now replaces methadone as the most common medicine for opioid dependence’: 10-year trends in opioid agonist treatment medicines in Australia

National Drug & Alcohol Research Centre Blog

Kendal Chidwick NDARC’s Kendal Chidwick discusses the findings from a recently published study that examined how patterns of opioid agonist treatment medicines have changed over the past decade. Other changes around this time aimed at improving treatment accessibility included increased use of take-home doses and telehealth appointments.

Treatment 133